Osmetech and Fisher HealthCare Sign U.S. Distribution Agreement

Osmetech plc (‘Osmetech’) (LSE: OMH), the international molecular diagnostics business, announces that it has signed a five-year distribution agreement with Fisher HealthCare, a part of Thermo Fisher Scientific, whereby Fisher HealthCare will distribute Osmetech’s eSensor XT-8 instrument platform and molecular diagnostic tests and consumables in the U.S.

James White, Chief Executive, Osmetech plc, said:

"We are delighted that Fisher HealthCare has partnered with Osmetech, highlighting the attraction of our eSensor XT-8 platform. Fisher HealthCare has a strong presence in the U.S. diagnostics market with a dedicated team of molecular sales specialists and over 150 leading edge healthcare sales representatives. We will work closely with Fisher HealthCare in order to capitalize on the significant market interest for our products and the growing number of customer leads.

"As we roll out our eSensor XT-8 platform, Fisher HealthCare’s considerable sales and marketing strength and established relationship with key customer accounts will play an important role in accelerating our market penetration.”

Mark Smits, Fisher HealthCare, said:

"We are excited by the opportunity to offer our customers Osmetech’s eSensor XT-8 system. It provides next-generation multiplex testing with industry leading standards in terms of speed and ease of use and is ideally suited for the needs of the rapidly growing and decentralizing molecular diagnostics market. The value proposition of the XT-8 for diagnostic laboratories and hospitals is compelling, enabling them to meet their objectives of improving patient care and enhancing the profitability of their operations. The planned expansion of the test menu will be very attractive to our customer base.”

About Osmetech plc

(www.osmetech.com)

Osmetech plc is an AIM-listed public company on the London Stock Exchange. The Company is a fast developing, international diagnostics business with operations in Boston and Pasadena in the US, serving the high growth molecular diagnostic market targeting hospitals and reference laboratories.

Osmetech has a strong portfolio of over 200 issued and pending patents and has launched its first generation eSensor 4800 platform, an electrochemistry-based array system, together with an FDA cleared in vitro diagnostic test for Cystic Fibrosis carrier detection.

Osmetech’s second generation platform, the eSensor XT-8 received FDA 510(k) clearance in July 2008 together with our eSensor Warfarin Sensitivity Test. These products are now being marketed in the U.S. together with a 2C9 Genotyping Test for drug metabolism and a Cystic Fibrosis carrier detection test which are both available for research use purposes only.

The eSensor XT-8 System is designed to support a broad menu of tests and Osmetech has scheduled for commercial launch a number of further tests including: extended warfarin panel with the proprietary 4F2 marker, venous thrombosis (Factor II, Factor V Leiden and MTHFR) and the RESPLEX II respiratory pathogen assay recently in-licensed from Qiagen. The System provides accurate results while minimizing technician involvement and its features compare favorably to those of other molecular detection systems. Its ease of use, readily interpretable results, speed and low maintenance are particularly suited to the needs of the decentralizing market.

About Thermo Fisher Scientific

Fisher HealthCare is part of Thermo Fisher Scientific, the world leader in serving science.

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling its customers to make the world healthier, cleaner and safer. With annual revenues of $10.5 billion, it has more than 34,000 employees and serves over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, the business helps solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, they offer the most convenient purchasing options to customers and continuously advance their technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.